吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

交易中 04-25 14:53:20 EDT

65.29

-1.79

-2.68%

最高67.90	最低65.26	成交量787.53万
今开67.45	昨收67.08	日振幅3.94%
总市值814.08亿	流通市值812.37亿	总股本12.47亿
成交额5.18亿	换手率0.63%	流通股本12.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":65.285,"timestamp":1714071199664,"preClose":67.08,"halted":0,"volume":7875266,"delay":0,"floatShares":1244337698,"shares":1246969303,"eps":4.5,"marketStatus":"交易中","marketStatusCode":2,"change":-1.795,"latestTime":"04-25 14:53:20 EDT","open":67.45,"high":67.8999,"low":65.26,"amount":518444275.05402,"amplitude":0.039355,"askPrice":65.28,"askSize":140,"bidPrice":65.27,"bidSize":339,"shortable":3,"etf":0,"ttmEps":4.5,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714075200000},"adr":0,"listingDate":696056400000,"adjPreClose":67.08,"adrRate":0,"dividendRate":0.045952,"preHourTrading":{"tag":"盘前","latestPrice":67.48,"preClose":67.08,"latestTime":"09:29 EDT","volume":10511,"amount":709307.08596,"timestamp":1714051799999},"postHourTrading":{"tag":"盘后","latestPrice":67.08,"preClose":67.08,"latestTime":"19:59 EDT","volume":1203216,"amount":80719706.538,"timestamp":1714003171295},"volumeRatio":1.301094,"optionData":{"bulkOrders":[{"symbol":"GILD","call":false,"expireDate":1715918400000,"strike":"62.0","timestamp":1714055591214,"price":0.4399999976158142,"volume":16828,"amount":740432,"type":"-"},{"symbol":"GILD","call":false,"expireDate":1715918400000,"strike":"66.0","timestamp":1714055591214,"price":1.7799999713897705,"volume":8414,"amount":1497692,"type":"+"}]}},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2430538712","title":"BUZZ-前瞻：吉利德科学公司下跌超过 2%，将于收盘后发布财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2430538712","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430538712?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:48","pubTimestamp":1714070919,"startTime":"0","endTime":"0","summary":"    4月25日 - ** 吉利德科学公司  的股价在周四下午的交易中下跌了2.6%，该公司将在收盘后公布季度业绩。** 根据伦敦证券交易所集团的数据，吉利德预计其营业收入将从一年前的63.5亿美元降至63.4亿美元，每股亏损1.49美元，而去年同期每股盈利1.37美元。** 根据LSEG的数据，该公司在过去8个报告期中，有6个报告期的盈利超过了分析师的预期。** 包括本交易日的走势在内，吉利德今年迄今下跌了19%，而同期标准普尔500指数  上涨了6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430890082","title":"吉利德科学下跌1.37%，报66.16美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430890082","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430890082?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:01","pubTimestamp":1714053687,"startTime":"0","endTime":"0","summary":"4月25日，吉利德科学(GILD)盘中下跌1.37%，截至22:01，报66.16美元/股，成交6962.42万美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学(美东)盘后披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/25220140414670.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430462500","title":"未来一天的看点 - 4月25日星期四","url":"https://stock-news.laohu8.com/highlight/detail?id=2430462500","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2430462500?lang=zh_cn&edition=full","pubTime":"2024-04-25 02:30","pubTimestamp":1713983434,"startTime":"0","endTime":"0","summary":"美国劳工部的每周失业救济申请数据可能会显示，在截至4月20日的一周内，各州首次申请失业救济的人数增加了3000人，经季节性因素调整后为215000人。与此同时，首次领取失业救济金的人数可能从截至4月13日当周的181.2万人降至180.5万人。美国航空公司将公布第一季度财报。由于主要市场需求低迷，陶氏预计将公布第一季度收入下降的报告。烟草巨头 Altria 将公布第一季度业绩。受客户转向广告流媒体的帮助，Roku 第一季度收入预计将增长 14.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429400841","title":"吉利德科学公司  预计每股亏损1.51美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2429400841","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429400841?lang=zh_cn&edition=full","pubTime":"2024-04-24 05:19","pubTimestamp":1713907181,"startTime":"0","endTime":"0","summary":"   * 吉利德科学公司   将于4月25日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。   * LSEG 分析师对吉利德科学公司的平均预期是每股亏损 1.51 美元。* 华尔街对吉利德科学公司 12 个月目标价的中位数为 80.00 美元，高于其上次收盘价 66.95 美元。4月23日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428668911","title":"美国研究综述-Blackstone、Ellington Financial、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2428668911","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428668911?lang=zh_cn&edition=full","pubTime":"2024-04-19 15:24","pubTimestamp":1713511479,"startTime":"0","endTime":"0","summary":"    路透社4月19日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括黑石集团、艾灵顿金融公司和 Netflix。要闻              * 黑石集团  ：Piper Sandler 将目标价从 146 美元下调至 143 美元             * Ellington Financial Inc   ：Jonestrading 给予其 \"持有 \"评级             * Netflix Inc   ：Pivotal Research将目标价从765美元上调至800美元 以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428567780","title":"瑞银：维持Gilead Sciences(GILD.US)评级，由中性调整至中性评级, 目标价由81.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428567780","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428567780?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:36","pubTimestamp":1713440183,"startTime":"0","endTime":"0","summary":"瑞银：维持Gilead Sciences(GILD.US)评级，由中性调整至中性评级, 目标价由81.00美元调整至75.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181936268b35e18e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181936268b35e18e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426783006","title":"BUZZ-Nurix Therapeutics 在增发 1.75 亿美元股票后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2426783006","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426783006?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:37","pubTimestamp":1712921821,"startTime":"0","endTime":"0","summary":"    4月12日 - ** Nurix Therapeutics Inc 的    股价在隔夜后续定价后盘前下跌 5.3%，报 16.30 美元。** 生物制药公司周四晚些时候宣布，  ~1170万股，包括150万份预筹资认股权证，发行价为15美元，筹资总额为1.75亿美元。** Nurix本月早些时候宣布延长与吉利德科学公司  的合作。2023 年第四季度，该公司与辉瑞  达成新的合作。** Nurix 拥有约 4 920 万股已发行股票，市值约 8.46 亿美元** 截至本周四，公司股价已累计上涨 67** 摩根大通、Piper Sandler 和 Stifel 担任股票发行的账簿管理人","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426296458","title":"吉利德科学上涨1.25%，报68.97美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426296458","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426296458?lang=zh_cn&edition=full","pubTime":"2024-04-12 02:08","pubTimestamp":1712858894,"startTime":"0","endTime":"0","summary":"4月12日，吉利德科学(GILD)盘中上涨1.25%，截至02:08，报68.97美元/股，成交2.17亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将于(美东)盘后披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/12020840206400.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425341542","title":"吉利德科学下跌1.23%，报70.02美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425341542","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425341542?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:35","pubTimestamp":1712255745,"startTime":"0","endTime":"0","summary":"4月5日，吉利德科学(GILD)盘中下跌1.23%，截至02:35，报70.02美元/股，成交2.25亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/05023540127771.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424846875","title":"吉利德科学下跌1.22%，报71.21美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424846875","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424846875?lang=zh_cn&edition=full","pubTime":"2024-04-04 02:30","pubTimestamp":1712169021,"startTime":"0","endTime":"0","summary":"4月4日，吉利德科学(GILD)盘中下跌1.22%，截至02:30，报71.21美元/股，成交1.73亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/04023040122363.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424209790","title":"吉利德科学下跌1.21%，报72.0美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424209790","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424209790?lang=zh_cn&edition=full","pubTime":"2024-04-03 01:35","pubTimestamp":1712079326,"startTime":"0","endTime":"0","summary":"4月3日，吉利德科学(GILD)盘中下跌1.21%，截至01:35，报72.0美元/股，成交1.8亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/03013540103960.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2423171813","title":"吉利德科学(GILD.US)超6亿美元囊获创新肿瘤免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2423171813","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2423171813?lang=zh_cn&edition=full","pubTime":"2024-03-29 07:50","pubTimestamp":1711669808,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月29日，吉利德科学和Xilio Therapeutics宣布达成一项总额可能超过6亿美元的独家许可协议，两家公司将共同开发和商业化Xilio的肿瘤激活白介素12蛋白XTX301，该在研药物目前处于临床1期阶段。XTX301目前正在治疗晚期实体瘤患者的1期剂量递增试验中接受评估。在Xilio交付XTX301的指定临床数据后，吉利德可以选择获得XTX301的开发和商业化权利，并支付7500万美元的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1096048.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422529449","title":"【医疗健康周报】第12周：创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资；生物制药公司“CymaBay”以约43亿美元被吉利德并购","url":"https://stock-news.laohu8.com/highlight/detail?id=2422529449","media":"钛媒体APP","top":-1,"share":"https://www.laohu8.com/m/news/2422529449?lang=zh_cn&edition=full","pubTime":"2024-03-27 16:37","pubTimestamp":1711528648,"startTime":"0","endTime":"0","summary":"国内投融资方面，医药领域，创新疫苗和佐剂开发商“华诺泰生物”获得6亿元人民币B轮融资，核医学CRDMO“米度生物”融资近4亿元人民币。国外投融资方面，医药领域，生物制药公司“CymaBay”以约43亿美元被吉利德并购；生物技术领域，生物技术公司“Capstan Therapeutics”在B系列融资中筹集了1.75亿美元。医药“华诺泰生物”获得6亿人民币B轮融资日前，“华诺泰生物”正式宣布完成总额6亿元B轮融资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271642038b68fa12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421071560","title":"吉利德科学下跌1.22%，报73.08美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2421071560","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2421071560?lang=zh_cn&edition=full","pubTime":"2024-03-22 03:53","pubTimestamp":1711050837,"startTime":"0","endTime":"0","summary":"3月22日，吉利德科学(GILD)盘中下跌1.22%，截至03:53，报73.08美元/股，成交2.72亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/22035339946722.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419655901","title":"吉利德科学下跌1.23%，报73.3美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2419655901","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2419655901?lang=zh_cn&edition=full","pubTime":"2024-03-16 00:02","pubTimestamp":1710518562,"startTime":"0","endTime":"0","summary":"3月16日，吉利德科学(GILD)盘中下跌1.23%，截至00:02，报73.3美元/股，成交2.59亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/16000239875543.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419237919","title":"到 2026 年，吉利德 CAR-T 癌症疗法的产能将翻两番","url":"https://stock-news.laohu8.com/highlight/detail?id=2419237919","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2419237919?lang=zh_cn&edition=full","pubTime":"2024-03-15 18:00","pubTimestamp":1710496855,"startTime":"0","endTime":"0","summary":"吉利德公司在 2017 年斥资近 120 亿美元收购了 Kite 公司，后者是 CAR-T 疗法这一新兴领域的领军企业之一，目前可治疗多种血癌。公司希望扩大 CAR-T 在美国的整体覆盖范围和市场份额。自2017年以来，六种获批的CAR-T产品已在美国施用了超过2.7万剂。最近，吉利德的 CAR-T 收入增长放缓，2023 年第四季度两种疗法的销售额连续下滑，约为 4.56 亿美元。该公司上个月表示，预计第一季度的CAR-T销售额将与上一季度持平或略有增长，但今年下半年的增长将有所回升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419659245","title":"吉利德科学上涨1.23%，报76.0美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2419659245","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2419659245?lang=zh_cn&edition=full","pubTime":"2024-03-14 02:54","pubTimestamp":1710356075,"startTime":"0","endTime":"0","summary":"3月14日，吉利德科学(GILD)盘中上涨1.23%，截至02:54，报76.0美元/股，成交2.16亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：4月25日，吉利德科学将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/14025439842219.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2417743147","title":"隔夜美股全复盘(3.8)| 三大股指集体收涨，英伟达涨逾4%，续创历史新高；诺和诺德大涨9%，口服减肥药Amycretin 3个月减重13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417743147","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2417743147?lang=zh_cn&edition=full","pubTime":"2024-03-08 05:21","pubTimestamp":1709846493,"startTime":"0","endTime":"0","summary":"三大股指集体收涨，英伟达涨逾4%，续创历史新高；诺和诺德大涨9%，口服减肥药Amycretin 3个月减重13%","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/703712","is_publish_highlight":false,"gpt_icon":0},{"id":"2417716283","title":"吉利德科学上涨1.21%，报73.51美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2417716283","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2417716283?lang=zh_cn&edition=full","pubTime":"2024-03-08 02:56","pubTimestamp":1709837792,"startTime":"0","endTime":"0","summary":"3月8日，吉利德科学(GILD)盘中上涨1.21%，截至02:56，报73.51美元/股，成交3.07亿美元。财务数据显示，截至2023年12月31日，吉利德科学收入总额271.16亿美元，同比减少0.6%；归母净利润56.65亿美元，同比增长23.37%。大事提醒：3月4日，吉利德科学获富国银行下调目标价至77美元，最新评级Equal Weight。4月25日，吉利德科学将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/08025639773438.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2417766651","title":"开发肿瘤靶向三特异性抗体！吉利德(GILD.US)与Merus达成超15亿美元合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2417766651","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2417766651?lang=zh_cn&edition=full","pubTime":"2024-03-07 21:26","pubTimestamp":1709817992,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月6日，吉利德宣布与Merus达成合作，双方将共同开发多款靶向新型肿瘤相关抗原的三特异性抗体。一旦行权，Merus将获得5600万美元的首付款以及2500万美元的股权投资，潜在交易金额超15亿美元。Merus官网公示的管线中均为双抗产品。2016年，Incyte与Merus就11个双特异性抗体达成合作。Incyte将支付1.2亿美元的预付款，并购买Merus8000万美元的普通股。此外，Merus还与礼来、先声药业、贝达药业等药企均有合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1083157.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":-0.0758},{"period":"3month","weight":-0.1639},{"period":"6month","weight":-0.1245},{"period":"1year","weight":-0.2163},{"period":"ytd","weight":-0.172}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.041198},{"month":2,"riseRate":0.393939,"avgChangeRate":0.002047},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.009403},{"month":4,"riseRate":0.545455,"avgChangeRate":0.014604},{"month":5,"riseRate":0.5625,"avgChangeRate":0.021083},{"month":6,"riseRate":0.625,"avgChangeRate":0.024943},{"month":7,"riseRate":0.53125,"avgChangeRate":0.013302},{"month":8,"riseRate":0.53125,"avgChangeRate":0.033833},{"month":9,"riseRate":0.5625,"avgChangeRate":0.031735},{"month":10,"riseRate":0.5,"avgChangeRate":-0.00096},{"month":11,"riseRate":0.625,"avgChangeRate":0.039318},{"month":12,"riseRate":0.40625,"avgChangeRate":0.011587}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}